Navigation Links
Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
Date:7/21/2011

ST. PAUL, Minn., July 21, 2011 /PRNewswire/ -- Prime Therapeutics (Prime), announced today that Michael Showalter has joined the company as chief marketing officer (CMO). As CMO, Showalter has overall responsibility for Prime's marketing and product development efforts, focused on helping the company continue to grow as a leading pharmacy benefit manager. Showalter's proven expertise in consumer-oriented strategies will also help prepare Prime for success as the market evolves.

"Michael brings an extensive track record of business strategy, health care marketing and product development expertise to the Prime team," said Eric Elliott, president and CEO, Prime. "I am confident that his diverse skills will allow us to leverage the value of pharmacy – the most frequently accessed component of the health care chain - to help shape our clients' success in the consumer-centric post-reform market. Michael's experience will help us continue to see significant growth, as we have in recent years, through industry-leading product development and helping us communicate Prime's differentiators as an integrated PBM focused on value and transparency."

Previously, Showalter served as the senior vice president of Enterprise Strategic Planning at CIGNA. Prior to that, he was CMO and the general manager of Consumer Driven Product Lines at CIGNA HealthCare, and vice president of Product and Public Affairs at Definity Health. He received his bachelor's degree in Speech/Communication from the University of Minnesota.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViaCyte Names Michael Scott Vice President, Device Research & Development
2. U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS TDI During Gala Event this November
3. Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinsons Cure
4. Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development
5. Lyle Arnold, PhD and Michael Dunn Join Biocept Management Team
6. NxStage® Names Michael Miller, Jr. President, International
7. Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
8. Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week
9. Xenon Chief Scientific Officer, Dr. Michael Hayden Receives Prestigious Award for Leadership in Medicine
10. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
11. Hill-Rom Elects Michael Macek as Treasurer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
Breaking Medicine News(10 mins):